Neuropsychiatric Disorders An Integrative Approach

ISBN: 978-3-211-73573-2 (Print) 978-3-211-73574-9 (Online)

Table of contents (41 chapters)

previous Page of 3
  1. Front Matter

    Pages I-IX

  2. No Access

    Book Chapter

    Pages 1-3

    The meeting of minds and times with Peter Riederer: an appreciation

  3. No Access

    Book Chapter

    Pages 5-15

    Succi nervorum: a brief history of neurochemistry

  4. No Access

    Book Chapter

    Pages 17-28

    Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y

  5. No Access

    Book Chapter

    Pages 29-34

    Endogenous oxidized indoles share inhibitory potency against [3H]isatin binding in rat brain

  6. No Access

    Book Chapter

    Pages 35-38

    Lipid content determines aggregation of neuromelanin granules in vitro

  7. No Access

    Book Chapter

    Pages 39-41

    Hydrogen peroxide is a true first messenger

  8. No Access

    Book Chapter

    Pages 43-49

    The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders

  9. No Access

    Book Chapter

    Pages 51-55

    Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis

  10. No Access

    Book Chapter

    Pages 57-67

    Luteolin protects rat PC 12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keapl-Nrf2-ARE pathway

  11. No Access

    Book Chapter

    Pages 69-85

    Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals

  12. No Access

    Book Chapter

    Pages 87-90

    Animal models in neurodegenerative diseases

  13. No Access

    Book Chapter

    Pages 91-104

    Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study

  14. No Access

    Book Chapter

    Pages 105-112

    Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture

  15. No Access

    Book Chapter

    Pages 113-120

    Biochemistry of postmortem brains in Parkinson’s disease: historical overview and future prospects

  16. No Access

    Book Chapter

    Pages 121-131

    Neuroprotection by propargylamines in Parkinson’s disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers

  17. No Access

    Book Chapter

    Pages 133-143

    Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson’s disease

  18. No Access

    Book Chapter

    Pages 145-148

    Low dose methylphenidate improves freezing in advanced Parkinson’s disease during off-state

  19. No Access

    Book Chapter

    Pages 149-154

    The long-term effects of the neurotoxin l-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) on cognitive performance in rats

  20. No Access

    Book Chapter

    Pages 155-158

    Observations on the cortical silent period in Parkinson’s disease

  21. No Access

    Book Chapter

    Pages 159-163

    CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity

previous Page of 3